Moderna Confirms 94% Efficiency Of Its Vaccine Candidate

Commenting on the 94% efficiency of Moderna’s Covid-19 vaccine candidate today’s trading, Gorilla Trades strategist Ken Berman said:Q3 2020 hedge fund letters, conferences and moreThe major indices are all trading lower following a bearish and active morning session on Wall Street. Moderna (MRNA, +16%) made headlines yet again this morning as the firm released new data confirming the 94% efficiency of its vaccine candidate, and announced that it will request emergency approval for the vaccine later today. Despite the positive developments, stocks gave back a large chunk of their gains from las…

Read More

HEDGE accordingly